Lipid-based vehicles for the oral delivery of poorly water soluble drugs

Advanced Drug Delivery Reviews

Volumn 25, Issue 1, 1997, Pages

  Humberstone, Andrew J ^a   Charman, William N ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Bioavailability; Dose form performance; Lipid digestion; Lipids; Poorly water soluble drugs

Indexed keywords

5 [5 [2,6 DICHLORO 4 (4,5 DIHYDRO 2 OXAZOLYL)PHENOXY]PENTYL] 3 METHYLISOXAZOLE; ALPHA TOCOPHEROL; BILE SALT; CINNARIZINE; COLECALCIFEROL; CORN OIL; CYCLOSPORIN; DICOUMAROL; DRUG VEHICLE; FATTY ACID; GRISEOFULVIN; LIPID; LONG CHAIN FATTY ACID; N4 ACETYLSULFAFURAZOLE; OLEIC ACID; PENCLOMEDINE; PHENYTOIN; PROBUCOL; PROGESTERONE; SESAME SEED OIL; SL 512; SOYBEAN OIL; STEROID; TEMAROTENE; TRIACYLGLYCEROL; TRIAMTERENE; TRIOCTANOIN; TRIOLEIN; UNCLASSIFIED DRUG;

DIGESTION; DISPERSION; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; EMULSION; GASTROINTESTINAL TRACT; HUMAN; INTESTINE LYMPH; NONHUMAN; ORAL DRUG ADMINISTRATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SOLID; SOLUBILIZATION; SUSPENSION;

EID: 0342617694     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(96)00494-2     Document Type: Review

References (105)

1. Bisgaier, C.I., and Glickman, R.M. (1983) Intestinal synthesis, secretion and transport of lipoproteins. Annu. Rev. Physiol. 45, 625-636.
2. Thomson, A.B.R., Keelan, M., Garg, M.L. and Clandinin, M.T. (1989) Intestinal aspects of lipid absorption: in review. Can. J. Physiol. Pharmacol. 67, 179-191.
3. Tso, P. (1994) Intestinal lipid absorption. In: L.R. Johnson (Ed.), Physiology of the Gastrointestinal Tract. Raven Press, New York, pp. 1867-1908.
4. Carey, MC., Small, D.M. and Bliss, C.M. (1983) Lipid digestion and absorption. Annu. Rev. Physiol. 45, 651-677.
5. Hamosh, M., Scanlon, J.W., Ganot, D., Likel, M., Scanlon, K.B. and Hamosh, P. (1981) Fat digestion in the newborn: characterization of lipase in gastric aspirates of premature and term infants. J. Clin. Invest. 67, 838-846.
6. Liao, T.H., Hamosh, P. and Hamosh, M. (1984) Fat digestion by lingual lipase: mechanism of lipolysis in the stomach and upper small intestine. Pediatr. Res. 18, 402-409.
7. Lowe, M.E. (1994) The structure and function of pancreatic enzymes. In: L.R. Johnson (Ed.), Physiology of the Gastroin-testinal Tract. Raven Press. New York, pp. 1531-1542.
8. 2 and fatty acid for the digestion of dietary fat. Gastroenterology 78, 954-962.
9. Bernback, S., Blackberg, L. and Hernell, O. (1989) Fatty acids generated by gastric lipase promote human milk triacylglycerol digestion by pancreatic colipase-dependent lipase. Biochim. Biophys. Acta 1001, 286-293.
10. Rautureau, M., Bisalli, A. and Rimbaud, J.C. (1981) Bile salts and lipids in the aqueous intraluminal phase during the digestion of a standard meal in man. Clin. Biol. 5, 417-425.
11. Carey, M.C. and Small, D.M. (1970) The characteristics of mixed micellar solutions with particular reference to man. Am. J. Med. 49, 590-608.
12. Carey, M.C. and Small, D.M. (1972) Micelle formation by bile salts. Arch. Intern. Med. 130, 506-527.
13. Bakatselou, V., Oppenheim, R.C. and Dressman, J.B. (1991) Solubilisation and wetting effects of bile salts on the dissolution of steroids. Pharm. Res. 8, 1461-1469.
14. Naylor, L.J., Bakatselou, V. and Dressman, J.B. (1993) Comparison of the mechanism of dissolution of hydro-cortisone in simple and mixed micelle systems. Pharm. Res. 10, 865-870.
15. Hofmann, A.F. and Borgstrom, B. (1962) Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc. 21, 43-50.
16. Hofmann, A.F. and Borgstrom, B. (1964) The intraluminal phase of fat digestion in man: The lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J. Clin. Invest. 43, 247-257.
17. Staggers, J.E., Hernell, O., Stafford, R.J. and Carey, M.C. (1990) Physical-chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behaviour and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry 29, 2028-2040.
18. Hernell, O., Staggers, J.E. and Carey, M.C. (1990) Physical-chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 29, 2041-2056.
19. Westergaard, H. and Dietschy, J.M. (1976) The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the mucosal cell. J. Clin. Invest. 58, 97-108.
20. Hoffmann, N.E. (1970) The relationship between uptake in vitro of oleic acid and micellar solubilisation. Biochim. Biophys. Acta 196, 193-203.
21. Simmonds, W.J. (1972) The role of micellar solubilisation in lipid absorption. Aust. J. Exp. Biol. Med. Sci. 50, 403-421.
22. Lucas, M.L., Schneider, W., Haberich, F.J. and Blair, J.A. (1975) Direct measurement by pH microelectrode in rat proximal jejunum. Proc. Royal Soc. B. 192, 39-48.
23. Shiau, Y. (1990) Mechanism of intestinal fatty acid uptake in the rat: the role of an acidic microclimate. J. Physiol. 421, 463-474.
24. Kiyasu, J.Y., Bloom, B. and Chaikoff, I.L. (1952) The portal transport of absorbed fatty acids. J. Biol. Chem. 199, 415-419.
25. McDonald, G.B. and Weidman, M. (1987) Partitioning of polar fatty acids into lymph and portal vein after intestinal absorption in the rat. Q. J. Exp. Physiol. 72, 153-159.
26. McDonald, G.B., Saunders, D.R., Weidman, M. and Fisher, L. (1980) Portal venous transport of long-chain fatty acids absorbed from rat intestine. Am. J. Physiol. 239, G141-G150.
27. Senior, J.R. and Isselbacher, K.J. (1962) Direct esterification of monoglycerides with palmityl coenzyme A by intestinal epithelial subcellular fractions. J. Biol. Chem. 237, 1454-1459.
28. Zilversmit, D.B. (1965) The composition and structure of lymph chylomicrons in dog, rat and man. J. Clin. Invest. 44, 1610-1622.
29. Charman, W.N. and Stella, V.J. (1986) Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules. Int. J. Pharm. 34, 175-178.
30. Charman, W.N. (1992) Lipid vehicle and formulation effects on intestinal lymphatic drug transport. In: W.N. Charman and V.J. Stella (Eds.), Lymphatic Transport of Drugs. CRC, Boca Raton, pp. 113-179.
31. Raub, T.J., Douglas, S.L., Melchior, G.W., Charman, W.N. and Morozowich, W. (1992) Methodologies for assessing intestinal lymphatic transport. In: W.N. Charman and V.J. Stella (Eds.), Lymphatic Transport of Drugs. CRC Press, Boca Raton, pp. 63-111.
32. Charman, W.N. and Porter, C.J.H. (1996) Lipophilic prodrugs designed for intestinal lymphatic transport. Adv. Drug Deliv. Rev. 19, 149-169.
33. Hunt, J.N. and Knox, M.T. (1968) A relation between the chain length of fatty acids and the slowing of gastric emptying. J. Physiol. 194, 327-336.
34. Khosla, R., Feely, L.C. and Davis, S.S. (1989) Gastrointestinal transit of non-disintegrating tablets in fed subjects. Int. J. Pharm. 53, 107-117.
35. Khosla, R. and Davis, S.S. (1989) Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects. Int. J. Pharm. 52, 1-10.
36. Gibaldi, M. and Feldman, S. (1970) Mechanisms of surfactant effects on drug absorption. J. Pharm. Sci. 59, 579-589.
37. Anderberg, E.K., Lindmark, T. and Artursson, P. (1993) Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. 10, 857-864.
38. Aungst, B.J. (1993) Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82, 979-987.
39. Swenson, E.S., Milisen, W.B. and Curatolo, W. (1994) Intestinal permeability enhancement: efficacy, acute local toxicity and reversibility. Pharm. Res. 11, 1132-1142.
40. Curatolo, W. and Ochoa, R. (1994) Safety assessment of intestinal permeability enhancers. In: A.G. de Boer (Ed.). Drug Absorption Enhancement. Harwood Academic. Switzerland, pp. 367-389.
41. Kvietys, P.R., Speian, R.D., Grisham, M.B. and Tso, P. (1991) Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Am. J. Physiol. 261, G384-G391.
42. Armstrong, N.A. and James, K.C. (1980) Drug release from lipid based dosage forms. Part 2. Int. J. Pharm. 6, 195-204.
43. Chakrabarti, S. and Belpaire, F.M. (1978) Bioavailability of phenytoin in lipid containing dosage forms in rats. J. Pharm. Pharmacol. 30, 330-331.
44. Hargrove, J.T., Maxson, W.S. and Wentz, A.C. (1989) Absorption of oral progesterone is influenced by vehicle and particle size. Am. J. Obstet. Gynecol. 161, 948-951.
45. Abrams, L.S., Weintraub, H.S., Patrick, J.E. and McGuire, J.L. (1978) Comparitive bioavailability of a lipophilic steroid. J. Pharm. Sci. 67, 1287-1290.
46. Yamaoka, Y., Roberts, R.D. and Stella, V.J. (1983) Low-melting phenytoin prodrugs as alternative oral delivery modes for phenytoin: a model for other high-melting sparingly water-soluble drugs. J. Pharm. Sci. 72, 400-405.
47. Stella, V., Haslam, J., Yata, N., Okada, H., Lindenbaum, S. and Higuchi, T. (1978) Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. J. Pharm. Sci. 67, 1375-1377.
48. Tokumura, T., Tsushima, Y., Tatsuishi, K., Kayano, M., Machida, Y. and Nagai, T. (1987) Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs. J. Pharm. Sci. 76, 286-288.
49. Carrigan, P.J. and Bates, T.R. (1973) Biopharmaceutics of drugs administered in lipid-containing dosage forms I: GI absorption of griseofulvin from an oil-in-water emulsion in the rat. J. Pharm. Sci. 62, 1476-1479.
50. Volpenhein, R.A., Webb, D.R. and Jandacek, R.J. (1980) Effect of nonabsorbable lipid, sucrose polyester, on the absorption of DDT by the rat. J. Tox. Environ. Health 6, 679-683.
51. Rozman, K., Ballhorn, L. and Rozman, T. (1983) Mineral oil in the diet enhances fecal excretion of DDT in the Rhesus monkey. Drug Chem. Toxicol. 6, 311-316.
52. Bloedow, D.C. and Hayton, W.L. (1976) Effects of lipids on bioavailability of sulfisoxazole acetyl, dicumerol and griseo-fulvin in rats. J. Pharm. Sci. 65, 328-334.
53. Patton, T.F. and Gilford, P. (1981) Effect of various vehicles and vehicle volumes on oral absorption of triamterene in rats. J. Pharm. Sci. 70, 1131-1134.
54. Yamahira, Y., Noguchi, T., Takenaka, H. and Maeda, T. (1979) Biopharmaceutical studies of lipid containing oral dosage forms: relationship between drug absorption rate and digestibility of vehicles. Int. J. Pharm. 3, 23-31.
55. Myers, R.A. and Stella, V.J. (1992) Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int. J. Pharm. 78, 217-226.
56. Reymond, J. and Sucker, H. (1988) In vitro model for cyclosporin intestinal absorption in lipid vehicles. Pharm. Res. 5, 673-676.
57. Reymond, J., Sucker, H. and Vonderscher, J. (1988) In vivo model for cyclosporin intestinal absorption in lipid vehicles. Pharm. Res. 5, 677-679.
58. Ritschel, W.A. (1991) Microemulsions for improved peptide absorption from the gastrointestinal tract. Meth. Find. Exp. Clin. Pharmacol. 13, 205-220.
59. Mehta, M.U., Venkataramanan, R., Burckart, G.J., Ptach-cinski, R.J., Dalamos, B., Stachak, S., Van Theil, D.H., Iwatsuki, S. and Starzl, T.E. (1988) Effect of bile on cyclosporin absorption in liver transplant patients. Br. J. Clin. Pharmacol. 25, 579-584.
60. Palin, K.J. and Wilson, C.M. (1984) The effect of different oils on the absorption of probucol in the rat. J. Pharm. Pharmacol. 36, 641-643.
61. 3 from two different lipid vehicles in man: comparison of peanut oil and medium chain triglyceride. Biopharm. Drug Dispos. 11, 807-815.
62. Gallo-Torres, H.E., Ludorf, J. and Brin, M. (1978) The effect of medium-chain triglycerides on the bioavailability of vitamin E. Int. J. Vit. Nutr. Res. 48, 240-249.
63. Bates, T.R. and Carrigan, P.J. (1975) Apparent absorption kinetics of micronized griseofulvin after its oral administration on single-and multiple-dose regimens to rats as a corn oil-in-water emulsion and aqueous suspension. J. Pharm. Sci. 64, 1475-1481.
64. Bates, T.R. and Sequeira, J.A. (1975) Bioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension and commercial tablet dosage forms in humans. J. Pharm. Sci. 64, 793-797.
65. Greenberger, N.J., Rodgers, J.B. and Isselbacher, K.J. (1966) Absorption of medium and long chain triglycerides: factors influencing their hydrolysis and transport. J. Clin. Invest. 45, 217-227.
66. Ritschel, W.A., Adolph, S., Ritschel, G.B. and Schroeder, T. (1990) Improvement of peroral absorption of cyclosporin by microemulsions. Meth. Find. Exp. Clin. Pharmacol. 12, 127-134.
67. Alvarez, F.J. and Stella, V.J. (1989) The role of calcium ions and bile salts on the pancreatic lipase-catalysed hydrolysis of trglyceride emulsions stabilised with lecithin. Pharm. Res. 6, 449-457.
68. Kimura, T., Fukui, E., Kageyu, A., Kurohara, Y., Nakayama, T., Morita, Y., Shibusawa, K., Ohsawa, S. and Takeda, Y. (1989) Enhancement of oral bioavailability of D-α-tocopherol acetate by lecithin-dispersed aqueous preparations containing medium-chain triglyceridies in rats. Chem. Pharm. Bull. 37, 439-441.
69. Fukui, E., Kurohara, H., Kageyu, A., Kurosaki, Y., Nakayama, T. and Kimura, T. (1989) Enhancing effect of medium-chain triglycerides on intestinal absorption of D-α-tocopherol acetate from lecithin-dispersed preparations in the rat. J. Pharmacobio-Dyn. 12, 80-86.
70. Serajuddin, A.T., Sheen, P., Mufson, D., Bernstein, D.F. and Augustine, M.A. (1988) Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions. J. Pharm. Sci. 77, 325-329.
71. Tarr, B.D. and Yalkowsky, S.H. (1989) Enhanced intestinal absorption of cyclosporin in rats through the reduction of emulsion droplet size. Pharm. Res. 6, 40-43.
72. Mueller, E.A., Kovarik, J.M., Van Bree, J.B., Tetzloff, W. and Kutz, K. (1994) Improved dose linearity of cyclosporin pharmacokinetics from a microemulsion formulation. Pharm. Res. 11, 301-304.
73. Mueller, E.A., Kovarik, J.M., Van Bree, J.B., Grevel, J. and Kutz, K. (1994) Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporin in a crossover comparison with the market formulation. Pharm. Res. 11, 151-155.
74. Kovarik, J.M., Mueller, E.A., Van Bree, J.B., Tetzloff, W. and Kutz, K. (1994) Reduced inter-and intra-individual variability in cyclosporin pharmacokinetics from a microemulsion formulation. J. Pharm. Sci. 83, 444-446.
75. Sketris, I.S., McAlister, V. and Wright, M.R. (1994) Increased cyclosporin bioavailability from a microemulsion formulation in a liver transplant recipient. Ann. Pharmacother. 28, 962-963.
76. Trull, A.K., Tan, K.K.C., Tan, L., Alexander, G.J.M. and Jamieson, N.V. (1995) Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion. Br. J. Clin. Pharmacol. 39, 627-631.
77. Charman, W.N., Rogge, M.C., Boddy, A.W. and Berger, B.M. (1993) Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J. Clin. Pharmacol. 33, 381-386.
78. Gupta, S.K., Manfro, R.C., Tomlanovich, S.J., Gambertoglio, J.G., Garovoy, M.R. and Benet, L.Z. (1990) Effect of food on the pharmacokinetics of cyclosporin in healthy subjects following oral and intravenous administration. J. Clin. Pharmacol. 30, 643-653.
79. Holt, D.W., Mueller, E.A., Kovarik, J.M., Van Bree, J.B. and Kutz, K. (1994) The pharmacokinetics of Sandimmune Neoral®: A new oral formulation of cyclosporin. Transplant. Proc. 26, 2935-2939.
80. Attwood, D. (1994) Microemulsions. In: J. Kreuter (Ed.), Colloidal Drug Delivery Systems. Marcel Dekker, Inc. New York, pp. 31-71.
81. Constantinides, P.P. (1995) Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12, 1561-1572.
82. Groves, M.J. and de Galindez, D.A. (1976) The self-emulsifying action of mixed surfactants in oil. Acta Pharm. Suec. 13, 361-372.
83. Groves, M.J., Mustafa, R.M.A. and Carless, J.E. (1974) Phase studies of mixed phosphated surfactants, n-hexane and water. J. Pharm. Pharmacol. 26, 616-623.
84. Groves, M.J. and Mustafa, R.M.A. (1974) Measurement of the 'spontaneity' of self-emulsifiable oils. J. Pharm. Pharmacol. 26, 671-681.
85. Pouton, C.W. (1985) Self-emulsifying drug delivery systems: assessment of their efficiency of emulsification. Int. J. Pharmaceut. 27, 335-348.
86. Wakerly, M.G., Pouton, C.W., Meakin, B.J. and Morton, F.S. (1986) Self-emulsification of vegetable oil-nonsurfactant mixtures: a proposed mechanism of action. Am. Chem. Soc. Symp. Ser. 311, 242-255.
87. Charman, S.A., Charman, W.N., Rogge, M.C., Wilson, T.D., Dutko, F.J. and Pouton, C.W. (1992) Self-emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm. Res. 9, 87-93.
88. Craig, D.Q.M., Lievens, H.S.R., Pitt, K.G. and Storey, D.E. (1993) An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int. J. Pharmaceut. 96, 147-155.
89. B receptor antagonist in dogs. Pharm. Res. 8, S-272 (Abstract)
90. Shah, N.H., Carvajal, M.T., Patel, C.I., Infeld, M.H. and Malick, A.W. (1994) Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharmaceut. 106, 15-23.
91. Ford, J.L. (1986) The current status of solid dispersions. Pharm. Acta Helv. 61, 69-88.
92. Chang, K.S. and Jarowski, C.I. (1980) Solid dispersion of morphine-tristearin with reduced presystemic inactivation in rats. J. Pharm. Sci. 69, 466-469.
93. Kind, F.A. and Rudel, H.W. (1986) Increasing intestinal absorption of drugs by formulation. Arch. Pharm. (Weinheim) 319, 615-624.
94. Venkataram, S. and Rogers, J.A. (1984) Characteristics of drug-phospholipid coprecipitates I: Physical properties and dissolution behaviour of griseofulvin-dimyristoylphos-phatidylcholine systems. J. Pharm. Sci. 73, 757-761.
95. Venkataram, S. and Rogers, J.A. (1988) Characteristics of drug-phosphoipid coprecipitates II: Bioavailability studies of griseofulvin in rats. J. Pharm. Sci. 77, 933-936.
96. Vudathala, G.K. and Rogers, J.A. (1992) Oral bioavailability of griseofulvin from aged griseofulvin: lipid coprecipitates: in vivo studies in rats. J. Pharm. Sci. 81, 1166-1169.
97. Serajuddin, A.T.M., Sheen, P., Mufson, D., Bernstein, D.F. and Augustine, M.A. (1988) Effect of vehicle amphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J. Pharm. Sci. 77, 414-417.
98. Sheen, P.C., Kim, S.I., Petillo, J.J. and Serajuddin, A.T. (1991) Bioavailability of a poorly water-soluble drug from tablet and solid dispersion in humans. J. Pharm. Sci. 80, 712-714.
99. Drewe, J., Meier, R., Vonderscher, J., Kiss, D., Posanski, U., Kissel, T. and Gyr, K. (1992) Enhancement of the oral absorption of cyclosporin in man. Br. J. Clin. Pharmacol. 34, 60-64.
100. Kinget, R. and De Greef, H. (1994) Absorption characteristics of novel 8-MOP semi-solid-lipid-matrix formulations: In vitro-in vivo correlation. Int. J. Pharm. 110, 65-73.
101. Vudathala, G.K. and Rogers, J.A. (1991) Effect of cholesterol on the aging of griseofulvin-phospholipid coprecipitates. Int. J. Pharmaceut. 69, 13-19.
102. Wu, C.Y., Benet, L.Z., Hebert, M.F., Gupta, S.K., Rowland, M., Gomez, D.Y. and Wacher, V.J. (1995) Differentiation of absorption, first-pass gut and hepatic metabolism in man: studies with cyclosporin. Clin. Pharmacol. Ther. 58, 492-497.
103. Benet, L.Z.,Wu, C.Y., Hebert, M.F. and Wacher, V.J. (1996) Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug delivery. J. Control. Rel. 39, 139-143.
104. Chang, T., Benet, L.Z. and Hebert, M.F. (1996) The effect of water soluble vitamin E on cyclosporin pharmacokinetics in healthy volunteers. Clin. Pharm. Ther. 59, 297-303.
105. Nerurkar, M.M., Burton, P.S. and Borchardt, R.T. (1996) The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm. Res 13, 528-534.